-

AAIC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Arlington Asset Investment Corp. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Arlington Asset Investment Corp. (NYSE: AAIC) to Ellington Financial Inc. is fair to Arlington shareholders. Under the terms of the merger agreement, (i) each share of Arlington common stock will be converted into 0.3619 shares of Ellington common stock, and (ii) Arlington common stockholders will also receive $0.09 per share. Upon the closing of the proposed acquisition, Arlington stockholders are expected to own approximately 15% of the combined company’s stock.

Halper Sadeh encourages Arlington shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The investigation concerns whether Arlington and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Arlington shareholders; (2) determine whether Ellington is underpaying for Arlington; and (3) disclose all material information necessary for Arlington shareholders to adequately assess and value the merger consideration. On behalf of Arlington shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh encourages Arlington shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Halper Sadeh LLC

NYSE:AAIC

Release Versions

Contacts

Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

More News From Halper Sadeh LLC

EQH Stock Alert: Halper Sadeh LLC is Investigating Whether Equitable Holdings, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Equitable Holdings, Inc. (NYSE: EQH) and Corebridge Financial, Inc. whereby each outstanding share of Equitable common stock will be exchanged for 1.55516 shares of the combined company’s common stock. Upon closing of the proposed transaction, Equitable shareholders will own approximately 49% of the combined company. Halper Sadeh encourages Equitable shareholders to click here to learn more...

CRBG Stock Alert: Halper Sadeh LLC is Investigating Whether Corebridge Financial, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Corebridge Financial, Inc. (NYSE: CRBG) and Equitable Holdings, Inc. whereby each outstanding share of Corebridge common stock will be exchanged for 1.0000 shares of the combined company’s common stock. Upon closing of the proposed transaction, Corebridge shareholders will own approximately 51% of the combined company. Halper Sadeh encourages Corebridge shareholders to click here to learn mo...

TERN Stock Alert: Halper Sadeh LLC is Investigating Whether Terns Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Terns Pharmaceuticals, Inc. (NASDAQ: TERN) to Merck for $53.00 per share in cash. Halper Sadeh encourages Terns shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Terns and its board of directors violated the fed...
Back to Newsroom